More concretely, RhGLP-1 lowered blood glucose in a dose-dependent manner while decreased the blood levels of biomarkers S100 Calcium Binding Protein B (S100B), major basic protein (MBP), and neuron specific enolase (NSE) which reflect cerebral damage (90) when administration implemented 2 weeks before transient middle cerebral artery occlusion (tMCAO) in diabetic rats
Deborah Roberts reports in The Skinny Confessions After Ozempic from IMPACT x Nightline on Hulu
Endogenous glutathione deficiency and impaired antioxidant defense systems have been increasingly recognized as central to the pathogenesis of many diseases, including COVID-19, through their impact on oxidative stress and inflammatory pathways
Cardiovascular and metabolic diseases including obesity remain important areas of unmet medical need, and we plan to continue applying our global capabilities to advance a pipeline of investigational treatments that have the potential to fill critical gaps in patient care, including continued development of our oral GIPR antagonist candidate and other earlier obesity programs, said Chris Boshoff, MD, PhD, Chief Scientific Officer and President, Research and Development at Pfizer
Similar trials for tirzepatide are ongoing, though early data suggest it could match or exceed semaglutide's cardiovascular efficacy
Patience is key, as Tirzepatide supports long-term changes rather than providing rapid, short-term results
